- Home
- PRCT vs CLDX Comparison
PRCT vs CLDX Comparison
Compare PRCT & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRCT | CLDX |
|---|---|---|
| Founded | 2009 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.9B |
| IPO Year | 2021 | 1995 |
Fundamental Metrics
Financial Performance| Metric | PRCT | CLDX |
|---|---|---|
| Price | $27.32 | $24.73 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 9 |
| Target Price | ★ $51.13 | $41.56 |
| AVG Volume (30 Days) | ★ 1.1M | 601.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 21.88 | 16.10 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $224,498,000.00 | $12,743,000.00 |
| Revenue This Year | $48.30 | N/A |
| Revenue Next Year | $29.44 | $23.23 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 64.84 | ★ 87.78 |
| 52 Week Low | $26.23 | $14.40 |
| 52 Week High | $70.80 | $30.50 |
Technical Indicators
Market Signals| Indicator | PRCT | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 39.58 | 50.20 |
| Support Level | N/A | $22.30 |
| Resistance Level | $30.02 | $26.06 |
| Average True Range (ATR) | 1.48 | 1.29 |
| MACD | -0.02 | 0.11 |
| Stochastic Oscillator | 29.02 | 73.21 |
Price Performance
Historical ComparisonAbout PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.